Novo Nordisk’s Alejandro Aguayo-Orozco to Present at 13th ARDD Meeting In
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Novo Nordisk’s Alejandro Aguayo-Orozco to Present at 13th ARDD Meeting in
BOSTON, Massachusetts—August 14, 2026—Aging research is moving rapidly from a largely academic pursuit into one of the most consequential frontiers in drug development, and the organizers of the 13th Aging Research & Drug Discovery (ARDD) Meeting say the field’s next phase will be defined by translation: converting discoveries about the biology of aging into medicines that can preserve health and function. ARDD 2026 will take place October 1–3 a…
Qiming Partner Kan Chen to Present at 13th ARDD Meeting in Boston
BOSTON, MA — August 14, 2026 — The global race to turn aging biology into medicines is moving to the center of biomedical science, as Insilico Medicine and the organizers of the Aging Research & Drug Discovery (ARDD) Meeting announce that Kan Chen, Ph.D., co-head of healthcare and partner at Qiming Venture Partners, will be […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
